<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T06:13:25Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4847210" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:4847210</identifier>
        <datestamp>2016-04-28</datestamp>
        <setSpec>bmcpedi</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">BMC Pediatr</journal-id>
              <journal-id journal-id-type="iso-abbrev">BMC Pediatr</journal-id>
              <journal-title-group>
                <journal-title>BMC Pediatrics</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1471-2431</issn>
              <publisher>
                <publisher-name>BioMed Central</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC4847210</article-id>
              <article-id pub-id-type="pmcid">PMC4847210</article-id>
              <article-id pub-id-type="pmc-uid">4847210</article-id>
              <article-id pub-id-type="pmid">27118537</article-id>
              <article-id pub-id-type="publisher-id">596</article-id>
              <article-id pub-id-type="doi">10.1186/s12887-016-0596-8</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Tracking post-infectious fatigue in clinic using routine Lab tests</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Harvey</surname>
                    <given-names>Jeanna M.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1"/>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Broderick</surname>
                    <given-names>Gordon</given-names>
                  </name>
                  <address>
                    <phone>+954.262.2866</phone>
                    <email>gbroderick@nova.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1"/>
                  <xref ref-type="aff" rid="Aff2"/>
                  <xref ref-type="aff" rid="Aff3"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bowie</surname>
                    <given-names>Alanna</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff3"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Barnes</surname>
                    <given-names>Zachary M.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Katz</surname>
                    <given-names>Ben Z.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff4"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>O’Gorman</surname>
                    <given-names>Maurice R. G.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff5"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Vernon</surname>
                    <given-names>Suzanne D.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff6"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Fletcher</surname>
                    <given-names>Mary Ann</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Klimas</surname>
                    <given-names>Nancy G.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Taylor</surname>
                    <given-names>Renee</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff7"/>
                </contrib>
                <aff id="Aff1"><label/>Department of Medicine, University of Miami, Miami, FL USA </aff>
                <aff id="Aff2"><label/>Institute for Neuro Immune Medicine, Nova Southeastern University, University Park Plaza, 3440 South University, Fort Lauderdale, 33328 FL USA </aff>
                <aff id="Aff3"><label/>University of Alberta, Edmonton, AB Canada </aff>
                <aff id="Aff4"><label/>Ann &amp; Robert H Lurie Children’s Hospital of Chicago, Chicago, IL USA </aff>
                <aff id="Aff5"><label/>Children’s Hospital Los Angeles, Los Angeles, CA USA </aff>
                <aff id="Aff6"><label/>Solve ME/CFS Initiative, Charlotte, NC USA </aff>
                <aff id="Aff7"><label/>University of Illinois at Chicago, Chicago, IL USA </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>26</day>
                <month>4</month>
                <year>2016</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>26</day>
                <month>4</month>
                <year>2016</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2016</year>
              </pub-date>
              <volume>16</volume>
              <elocation-id>54</elocation-id>
              <history>
                <date date-type="received">
                  <day>3</day>
                  <month>9</month>
                  <year>2014</year>
                </date>
                <date date-type="accepted">
                  <day>21</day>
                  <month>4</month>
                  <year>2016</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© Harvey et al. 2016</copyright-statement>
                <license license-type="OpenAccess">
                  <license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <sec>
                  <title>Background</title>
                  <p>While biomarkers for chronic fatigue syndrome (CFS) are beginning to emerge they typically require a highly specialized clinical laboratory. We hypothesized that subsets of commonly measured laboratory markers used in combination could support the diagnosis of post-infectious CFS (PI-CFS) in adolescents following infectious mononucleosis (IM) and help determine who might develop persistence of symptoms.</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p>Routine clinical laboratory markers were collected prospectively in 301 mono-spot positive adolescents, 4 % of whom developed CFS (<italic>n</italic> = 13). At 6, 12, and 24 months post-diagnosis with IM, 59 standard tests were performed including metabolic profiling, liver enzyme panel, hormone profiles, complete blood count (CBC), differential white blood count (WBC), salivary cortisol, and urinalysis. Classification models separating PI-CFS from controls were constructed at each time point using stepwise subset selection.</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p>Lower ACTH levels at 6 months post-IM diagnosis were highly predictive of CFS (AUC <italic>p</italic> = 0.02). ACTH levels in CFS overlapped with healthy controls at 12 months, but again showed a trend towards a deficiency at 24 months. Conversely, estradiol levels depart significantly from normal at 12 months only to recover at 24 months (AUC <italic>p</italic> = 0.02). Finally, relative neutrophil count showed a significant departure from normal at 24 months in CFS (AUC <italic>p</italic> = 0.01). Expression of these markers evolved differently over time between groups.</p>
                </sec>
                <sec>
                  <title>Conclusions</title>
                  <p>Preliminary results suggest that serial assessment of stress and sex hormones as well as the relative proportion of innate immune cells measured using standard clinical laboratory tests may support the diagnosis of PI-CFS in adolescents with IM.</p>
                </sec>
                <sec>
                  <title>Electronic supplementary material</title>
                  <p>The online version of this article (doi:10.1186/s12887-016-0596-8) contains supplementary material, which is available to authorized users.</p>
                </sec>
              </abstract>
              <kwd-group xml:lang="en">
                <title>Keywords</title>
                <kwd>Blood glucose</kwd>
                <kwd>ACTH</kwd>
                <kwd>Estradiol</kwd>
                <kwd>Neutrophil count</kwd>
                <kwd>Free thyroxin</kwd>
                <kwd>Salivary cortisol</kwd>
                <kwd>Classification models</kwd>
                <kwd>Infectious mononucleosis</kwd>
                <kwd>EBV</kwd>
                <kwd>Chronic fatigue</kwd>
              </kwd-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© The Author(s) 2016</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1">
              <title>Background</title>
              <p>Chronic Fatigue Syndrome (CFS) is a complex, multi-symptom illness involving persistent fatigue, musculoskeletal symptoms, as well as cognitive impairment [<xref ref-type="bibr" rid="CR1">1</xref>]. Studies show that CFS affects between 1 and 4 million individuals [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>] and costs an estimated $35 billion per year in health care and lost productivity [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. CFS affects roughly 0.2 % of the general adolescent population [<xref ref-type="bibr" rid="CR6">6</xref>] and is a major cause of educational disruption [<xref ref-type="bibr" rid="CR7">7</xref>–<xref ref-type="bibr" rid="CR10">10</xref>]. While viral serology is not necessary for diagnosis, CFS follows infection in at least a subset of cases [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. In adults, symptom onset coincided with apparent infection in up to 72 % of cases; [<xref ref-type="bibr" rid="CR12">12</xref>] in adolescents, infectious mononucleosis (IM) is the most commonly reported antecedent infection [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR13">13</xref>–<xref ref-type="bibr" rid="CR15">15</xref>]. The reported incidence of CFS following IM is 9-12 % [<xref ref-type="bibr" rid="CR16">16</xref>–<xref ref-type="bibr" rid="CR19">19</xref>]. Females appear more susceptible than males [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. Consistent with this, our group reported previously that 13, 7 and 4 % of adolescents met criteria for CFS at 6, 12 and 24 months respectively post-IM, and at 6 months post-IM, 90 % of the subjects with CFS were female, while at 12 and 24 months, 100 % were female [<xref ref-type="bibr" rid="CR22">22</xref>].</p>
              <p>Diagnosis of CFS currently relies on exclusion of other medical or psychological causes [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. Currently there are no validated diagnostic test, although Klimas et al. [<xref ref-type="bibr" rid="CR25">25</xref>] have reviewed some candidate biomarkers. Confirming many but not all past reports, Brenu et al. [<xref ref-type="bibr" rid="CR26">26</xref>] and Fletcher et al. [<xref ref-type="bibr" rid="CR27">27</xref>] found natural killer (NK) cell cytotoxicity to be low. Fletcher et al. [<xref ref-type="bibr" rid="CR28">28</xref>] also found evidence that Neuropeptide Y, an immunologically active neurotransmitter, was elevated in subjects with CFS and correlated with symptom severity. Mild hypocortisolism with attenuated diurnal variation has also been reported in some patients with CFS [<xref ref-type="bibr" rid="CR29">29</xref>]. In addition to the early identification of potential individual candidate markers, studies using multiplex methods have reported broader surveys and more detailed analyses. For example, while Curriu et al. [<xref ref-type="bibr" rid="CR30">30</xref>] found similar cell counts for T, B, and NK cell populations in general in healthy individuals and subjects with CFS (<italic>n</italic> = 22), the latter showed significant increases in the T-helper and regulatory T cell subsets. NK cells also showed higher levels of specific activation markers (e.g., CD69). Suggesting altered patterns of immune signaling, Broderick et al. [<xref ref-type="bibr" rid="CR31">31</xref>] found that a subset of 5 cytokines used in combination supported an accuracy of better than 80 % at a confidence level of 0.95 in separating subjects with post-IM CFS versus recovered controls.</p>
              <p>In the present work we focused on common clinical laboratory assays measured longitudinally to explore whether a combination of such markers could act as a signature for CFS following IM. We reviewed commonly recorded laboratory data collected during a 2-year prospective study of 301 adolescents with mono-spot positive IM conducted by Katz et al. [<xref ref-type="bibr" rid="CR22">22</xref>] in the greater Chicago area. In this study 4 % of subjects met criteria for CFS per the Jason et al. revision [<xref ref-type="bibr" rid="CR32">32</xref>] of the Fukuda criteria [<xref ref-type="bibr" rid="CR1">1</xref>]. Fifty-nine standard blood, saliva, and urine tests, such as CBC with differential, metabolic profiling, and urinalysis, were performed at each time point. Linear classification models separating post-IM CFS from controls were constructed at each time point based on subsets of these markers selected iteratively. While the vast majority of these markers were uninformative, changes in ACTH, estradiol, and relative neutrophil count across the 2-year period were discriminatory for post-infectious CFS (PI-CFS) with an accuracy ranging from 72 to 84 %.</p>
              <sec id="Sec2">
                <title>Methods</title>
                <sec id="Sec3">
                  <title>Cohort and clinical assessment</title>
                  <p>A total of 301 adolescents, ages 12–18, with a diagnosis of monospot positive acute IM were recruited on a referral basis from the greater Chicago area via school nurses, pediatric practices, and the Virology Laboratory of Children’s Memorial Hospital (now the Ann &amp; Robert H Lurie Children’s Hospital of Chicago) between September of 2004 and November of 2007. The presumption was that most cases of monospot-positive acute IM were caused by Epstein-Barr virus (EBV) infection. Of the 301 initially enrolled, 286 adolescents who were not fully recovered as well as those who recovered uneventfully (controls) successfully completed the telephone-based interview using the CFS Screening Questionnaire [<xref ref-type="bibr" rid="CR33">33</xref>] and underwent evaluation at 6, 12, and 24 months post-IM. Of these subjects, 13, 7, and 4 % (<italic>n</italic> = 13) respectively met the Jason et al. revision [<xref ref-type="bibr" rid="CR32">32</xref>] of the Fukuda [<xref ref-type="bibr" rid="CR1">1</xref>] case definition for CFS. The former also incorporates elements of the Canadian case definition reported in Carruthers et al. [<xref ref-type="bibr" rid="CR23">23</xref>]. Ninety percent of subjects who met the CFS case definition at 6 months were female, and at 12 and 24 months, 100 % of subjects who met the case definition were female. At 6, 12, and 24 months post-IM, blood, saliva, and urine samples were collected from cases and controls for laboratory analysis. Details of the full cohort are reported in Katz et al. [<xref ref-type="bibr" rid="CR22">22</xref>]. In the present study we focus on the specific subset of 13 female adolescents, representing 4 % of the initial cohort of over 300 adolescents, who fit the case definition of CFS at 6, 12 and 24 months following diagnosis with IM. These adolescents were compared to <italic>n</italic> = 12 female control subjects, case-matched on the basis of gender, age (+/− 1 year, with 1 exception) and Tanner breast and pubic hair stage (4 or 5, with one exception), who recovered normally following the same infection. All subjects were menarchal. None of the patients were on significant, chronic medications. Five were on no medications. Four reported occasional inhalers for asthma, or Advil. Three were on birth control. One patient was on methylphenidate (Concerta), one had a history of clonidine use in the past and one reported 1 or 2 doses of Xanax per year because of fear of flying.</p>
                </sec>
                <sec id="Sec4">
                  <title>Ethics statements</title>
                  <p>All aspects of the study were approved by the Institutional Review Boards of Children’s Memorial Research Center (now the Stanley Manne Research Institute) and the College of Applied Sciences of the University of Illinois at Chicago. Written informed consent was obtained from all participants age 18 years or older. For those subjects less than 18 years of age, written informed consent was obtained from their guardians, coupled with mandatory child assent. Secondary analysis of the biological samples and data was reviewed and approved by the Institutional Review Board of the University of Alberta.</p>
                </sec>
                <sec id="Sec5">
                  <title>Laboratory measurements</title>
                  <p>Morning fasting blood samples were collected into ethylene diamine tetra acetic acid (EDTA) anticoagulant tubes from cases and controls at 6, 12, and 24 months following the diagnosis of monospot positive, acute IM. Where appropriate plasma was separated within 2 h of collection and stored at -80oC until assayed. A total of 59 standard laboratory tests were performed according to Good Clinical Laboratory Practice standards on blood and urine, including complete blood count with differential, metabolic profiling, erythrocyte sedimentation rate, liver enzymes, thyroid, adrenal, and sex hormone profiling, and urinalysis. Cortisol was isolated from passive drool with a solid phase extraction protocol using a Micromass Quattro Micro triple-quadrupole mass spectrometer equipped with a Z-spray ion source and a Waters 2795 Alliance HT HPLC system as described in Katz et al. [<xref ref-type="bibr" rid="CR34">34</xref>] Summary statistics for the expression of these markers are shown in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Tables S1a-d.</p>
                </sec>
                <sec id="Sec6">
                  <title>Statistical analyses</title>
                  <p>To assess the significance of changes in the mean expression of individual markers occurring across each of these patient groups versus recovering controls, we used a standard parametric <italic>t</italic>-test after performing a logarithmic transformation. In conjunction with this, a nonparametric Wilcoxon rank-sum test was used to compare the difference in group-wise median expression for each marker at each time point. The significance of the effects for time and time x group interactions were assessed using a conventional 2-way ANOVA and verified further using a regression-based repeated measures analysis. These calculations were performed using the <italic>annovan</italic> as well as the <italic>fitrm</italic> and <italic>ranovatbl</italic> functions available in the MatLab Statistics Toolbox (The MathWorks, Inc., Natick, MA).</p>
                  <p>Individual markers were assessed using different laboratory assays. In conventional multiple testing problems this heteroscedasticity or non-uniform variance can be removed by rescaling. However, when the null hypothesis involves correlated markers as it does here, such a rescaling step is known to distort the result and methods to address this issue still constitute an active field of research [<xref ref-type="bibr" rid="CR35">35</xref>]. Thus, raw null probability <italic>p</italic>-values are more appropriate in this situation determining the significance of group-wise changes. Nevertheless, we estimated false discovery rates (FDR) using both the more exploratory measure proposed by Storey [<xref ref-type="bibr" rid="CR36">36</xref>] and the more conservative measure of Benjamini and Hochberg [<xref ref-type="bibr" rid="CR37">37</xref>]. In the case of the Storey [<xref ref-type="bibr" rid="CR36">36</xref>] FDR, we estimated the tuning parameter lambda (λ) using both a bootstrap method and a polynomial regression. We found the latter to support more conservative estimates of FDR in this data set. FDR calculations were performed using the <italic>mafdr</italic> function available in the MatLab Statistics Toolbox (The MathWorks, Inc., Natick, MA).</p>
                  <p>In addition, we examined patterns of expression in multiple markers at the level of individual subjects to address the non-homogeneous nature of these groups. This was done by constructing linear discriminant classification models using a stepwise feature selection method to mitigate the effect of cross-correlation between markers [<xref ref-type="bibr" rid="CR38">38</xref>]. Such regression models favor marker subsets that are minimally redundant [<xref ref-type="bibr" rid="CR39">39</xref>]. Model terms were selected sequentially based on their respective partial-F test values. Markers with a null probability p(partial F) &lt; 0.05 were selected for recruitment into the regression model while those currently in the model but showing a revised p(partial F) &gt; 0.10 were removed. In the resulting model, an observed row × from the sample set is classified into group I rather than group J if 0 &lt; B<sub>0</sub> + x*B, where the coefficient vector B and intercept vector B<sub>0</sub> are estimated from the data. All markers were normalized a priori using a conventional z-score to a mean value of 0 and a variance of 1.0 with observations at 6 months serving as the reference datum. Classifiers were evaluated based on their overall error rate (incorrectly classified/total classified) in assigning subjects to their proper diagnostic group. Detection sensitivity and assignment specificity were then computed over a range of threshold values B<sub>0</sub> to produce a receiver-operator characteristic (ROC) curve [<xref ref-type="bibr" rid="CR40">40</xref>]. These calculations were performed using the <italic>classify, classperf, rankfeatures and randfeatures</italic> functions available in the MatLab Statistics Toolbox and the MatLab Bioinformatics Toolbox (The MathWorks, Inc., Natick, MA) as well as with the SPSS Statistics Release 21.0 software package (IBM, New York, NY). For a further introduction and review of these statistical measures as they might apply more to clinical practice we refer the reader to [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>].</p>
                </sec>
              </sec>
            </sec>
            <sec id="Sec7">
              <title>Results</title>
              <p>The results of the parametric t-tests and nonparametric Wilcoxon rank-sum tests performed on all standard blood work, salivary tests, and urinalysis measures are presented in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Tables S1a-d. At 6 months, those with PI-CFS were found to have depressed glucose (<italic>p</italic> = 0.03, ranksum <italic>p</italic> = 0.05) and depressed ACTH (<italic>p</italic> = 0.01, ranksum <italic>p</italic> = 0.02) compared with controls. At 12 months, those with PI-CFS were found to have depressed estradiol compared with controls (<italic>p</italic> = 0.01, ranksum <italic>p</italic> = 0.02), and at 24 months, those with PI-CFS had higher levels of neutrophils compared with controls (<italic>p</italic> =0.02, ranksum <italic>p</italic> = 0.01). Although this did not meet statistical significance, we also found elevated free thyroxine (T4) at both 6 (<italic>p</italic> = 0.07) and 12 months (<italic>p</italic> = 0.08). In this group-wise comparison conducted separately at each time point none of the <italic>p</italic>-values obtained, whether by <italic>t</italic> test or ranksum test, corresponded to a FDR of less than 0.20. This suggests that if values are considered independent from one visit to the next the probability of an incidental finding is high. However when analyzing the full time course using a 2-way ANOVA (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S2), we found a significant group effect for elevated free thyroxine (T4) (<italic>p</italic> = 0.01; FDR = 0.01, FDR <sub>BH</sub> = 0.26) and depressed morning salivary cortisol (<italic>p</italic> = 0.03; FDR = 0.02, FDR <sub>BH</sub> = 0.29) as well as significant time (<italic>p</italic> = 0.01; FDR = 0.02, FDR <sub>BH</sub> = 0.11) and group effects for ACTH (<italic>p</italic> = 0.01; FDR = 0.03, FDR <sub>BH</sub> = 0.26). All three of these markers, namely free thyroxine (T4), morning salivary cortisol and ACTH demonstrated group effects that satisfied a FDR &lt; 0.05 based on Storey [<xref ref-type="bibr" rid="CR36">36</xref>] using a polynomial estimate for the tuning factor lambda (λ). In none of the markers studied were we able to find a change in the slope of the trend from one subject group to the next (i.e., time × group effect). These results were largely confirmed when performing a complementary analysis using a regression-based repeated measure model (Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Tables S3a - d) with the exception of a few minor differences in the significance of the time effect only. Once again no significant time x group effects were identified.</p>
              <p>When linear regression models were applied, one variable, unique at each time point, was selected as being the most suitable to distinguish between individuals recovering normally and those who progressed to PI-CFS. At 6, 12, and 24 months, ACTH, estradiol, and neutrophils, respectively, were highly discriminatory for PI-CFS. As shown in Table <xref rid="Tab1" ref-type="table">1</xref>, at 6 months, the model based on depressed ACTH levels produced an accuracy of 72 %, a negative predictive value (NPV) of 73 %, positive predictive value (PPV) of 71 %, specificity of 67 %, and sensitivity of 77 %. In comparison, low glucose levels supported a slightly higher PPV (75 %) and specificity (75 %), but lower NPV (69 %) and sensitivity (69 %). Similarly at 12 months, the model based on depressed estradiol alone produced an accuracy of 76 %, a NPV of 75 %, a PPV of 77 %, with a specificity of 75 %, and a sensitivity of 77 %. The classification accuracy increases as the sample time approaches 24 months. When applied to subject classification at 24 months, the model based on increased neutrophil count produced an accuracy of 84 % corresponding to a NPV of 83 %, PPV of 85 %, specificity of 83 %, and sensitivity of 85 %.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Identification and performance of linear classification models. Classification of PI-CFS and healthy recovered control (RC) subjects at 6, 12 and 24 months post-diagnosis with IM using linear discriminant models with terms identified as optimal at each time point based on classical stepwise variable selection with the exception of classification based on glucose levels at 6 months which was specified based on differential expression</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Model</th><th>Assigned RC</th><th>Assigned PI-FS</th><th>Total</th><th/><th>Accuracy</th><th>NPV</th><th>PPV</th><th>Specificity</th><th>Sensitivity</th></tr></thead><tbody><tr><td>6 months</td><td/><td/><td/><td/><td/><td/><td/><td/><td/></tr><tr><td> ACTH</td><td>8</td><td>4</td><td>12</td><td>True RC</td><td>0.72</td><td>0.73</td><td>0.71</td><td>0.67</td><td>0.77</td></tr><tr><td/><td>3</td><td>10</td><td>13</td><td>True PI-CFS</td><td/><td/><td/><td/><td/></tr><tr><td> Glucose</td><td>9</td><td>3</td><td>12</td><td>True RC</td><td>0.72</td><td>0.69</td><td>0.75</td><td>0.75</td><td>0.69</td></tr><tr><td/><td>4</td><td>9</td><td>13</td><td>True PI-CFS</td><td/><td/><td/><td/><td/></tr><tr><td>12 months</td><td/><td/><td/><td/><td/><td/><td/><td/><td/></tr><tr><td> Estradiol</td><td>9</td><td>3</td><td>12</td><td>True RC</td><td>0.76</td><td>0.75</td><td>0.77</td><td>0.75</td><td>0.77</td></tr><tr><td/><td>3</td><td>10</td><td>13</td><td>True PI-CFS</td><td/><td/><td/><td/><td/></tr><tr><td>24 months</td><td/><td/><td/><td/><td/><td/><td/><td/><td/></tr><tr><td> Neutrophils</td><td>10</td><td>2</td><td>12</td><td>True RC</td><td>0.84</td><td>0.83</td><td>0.85</td><td>0.83</td><td>0.85</td></tr><tr><td/><td>2</td><td>11</td><td>13</td><td>True PI-CFS</td><td/><td/><td/><td/><td/></tr></tbody></table></table-wrap></p>
              <p>Table <xref rid="Tab2" ref-type="table">2</xref> shows a summary of receiver operating characteristic (ROC) performance for classification of PI-CFS subjects at 6, 12, and 24 months post-diagnosis of IM using linear discriminant models with terms selected as optimal at each time point. Classification for the eventual onset of post-IM CFS at the 2-year time point based on ACTH levels measured at 6 months produced an area under the curve (AUC) of 0.77 (<italic>p</italic> = 0.02). In comparison, glucose measured at 6 months only supports an AUC value of 0.73 (<italic>p</italic> = 0.05). Estradiol levels measured at 12 months produced a classification for illness at 24 months with an AUC value of 0.78 (<italic>p</italic> = 0.02). Finally, illness at 24 months was predicted based on the relative level of neutrophils at that same time point with a highly significant value for the AUC of 0.83 (<italic>p</italic> = 0.01). The ROC curves produced based on measures taken at each time point are presented in Fig. <xref rid="Fig1" ref-type="fig">1</xref> for the markers selected by stepwise regression, namely ACTH, estradiol and relative neutrophil count. The evolution across the 2-year period of all 4 differentially expressed markers is presented in Fig. <xref rid="Fig2" ref-type="fig">2</xref>.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Summary of receiver operating characteristic (ROC) performance. Area under the classification curve (AUC) for assignment of PI-CFS subjects at 6, 12 and 24 months post-diagnosis with IM using a linear discriminant models with terms selected as optimal at each time point using s stepwise selection method. Classification performance based on glucose levels measured at 6 months is included for comparison and was specified on the basis of t and ranksum tests</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th rowspan="2">Area</th><th rowspan="2">Std. error<sup>a</sup>
</th><th rowspan="2">Asymptotic Sig.<sup>b</sup>
</th><th colspan="2">Asymptotic 95 % Conf. interval</th></tr><tr><th>Model</th><th>Lower bound</th><th>Upper bound</th></tr></thead><tbody><tr><td>ACTH (6 months)</td><td>0.77</td><td>0.10</td><td>0.02</td><td>0.58</td><td>0.96</td></tr><tr><td>Glucose (6 months)<sup>c</sup>
</td><td>0.73</td><td>0.11</td><td>0.05</td><td>0.52</td><td>0.95</td></tr><tr><td>Estradiol (12 months)</td><td>0.78</td><td>0.09</td><td>0.02</td><td>0.60</td><td>0.97</td></tr><tr><td>Neutrophil (24 months)</td><td>0.83</td><td>0.09</td><td>0.01</td><td>0.64</td><td>1.00</td></tr></tbody></table><table-wrap-foot><p>The test result variable(s): acth1 has at least one tie between the positive actual state group and the negative actual state group. Statistics may be biased</p><p><sup>a</sup>Under the nonparametric assumption</p><p><sup>b</sup>Null hypothesis: true area = 0.5</p><p><sup>c</sup>Model specified on the basis of t and ranksum tests, not as a result of stepwise selection</p></table-wrap-foot></table-wrap><fig id="Fig1"><label>Fig. 1</label><caption><p>Performance of subject classification based on a minimal set of standard clinical assays. ROC curves for classification of subjects who went on to develop post-infectious chronic fatigue syndrome and subjects who recovered normally using a linear discriminant model selected as optimal based on data collected at 6, 12 and 24-month time points using a stepwise selection method. Coefficients were tuned based on data collected at each time point only</p></caption><graphic xlink:href="12887_2016_596_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig. 2</label><caption><p>Time course progression in expression of key discriminatory makers. Evolution of ACTH concentration (<bold>a</bold>), glucose concentration (<bold>b</bold>), estradiol concentration (<bold>c</bold>) and neutrophil count (<bold>d</bold>) in blood collected at 6, 12 and 24 months post-diagnosis with IM in subjects who went on to develop post-infectious chronic fatigue syndrome (PI-CFS; red square) and normally recovered control subjects (RC; blue triangle)</p></caption><graphic xlink:href="12887_2016_596_Fig2_HTML" id="MO2"/></fig></p>
            </sec>
            <sec id="Sec8">
              <title>Discussion</title>
              <p>The diagnosis of CFS currently relies on the exclusion of other medical and psychiatric diseases. We sought to determine if standard laboratory analysis of blood, salivary, and urine markers used alone or in combination might support the identification of individuals likely to develop PI-CFS. In the adolescent population studied we found significantly lower levels of glucose and ACTH 6 months following IM in individuals who 18 months later would continue to suffer with persistent symptoms. Glucose was not selected as a distinguishing variable using stepwise regression even though it displayed similar predictive power because of a strong overlap with similar changes in ACTH. Changes in glucose homeostasis during infection are context-dependent and poorly understood [<xref ref-type="bibr" rid="CR43">43</xref>] with cytokines such as IL-6 reportedly promoting hypoglycemia during acute LPS-induced inflammation [<xref ref-type="bibr" rid="CR44">44</xref>]. Interestingly relative expression of the latter emerged as a distinguishing feature for this illness group in our previous work [<xref ref-type="bibr" rid="CR31">31</xref>]. In addition, significantly lower levels of estradiol and increased relative neutrophil count were also observed 12 and 24 months post-IM (Table <xref rid="Tab1" ref-type="table">1</xref>). The accuracy of each individual marker in identifying individuals who develop PI-CFS at 24 months ranged between 72-84 %. The fact that different markers discriminated better at different times might highlight the dynamic nature of the immune and endocrine responses to this insult, which could be characterized as progressive. In several markers a persistent offset appears to be acquired quite early however the nonlinear nature of these changes is not easily captured by traditional linear analysis, e.g., the 2-way ANOVA employed herein. Because of this, single assessments will be of limited value while serial assessments within the first year may be much better suited for aiding in diagnosis of these subjects (e.g., serial estradiol measurements).</p>
              <p>CFS is a complex constellation of symptoms [<xref ref-type="bibr" rid="CR25">25</xref>]. Cannon et al. [<xref ref-type="bibr" rid="CR45">45</xref>] found sex hormone driven changes in neutrophil count characteristic of CFS. The latter reported that while neutrophil count normally increases from the follicular to luteal phase in healthy women, it persists at luteal levels in CFS. Niblett et al. [<xref ref-type="bibr" rid="CR46">46</xref>] also found that the neutrophil count and ratio of neutrophils to lymphocytes were both increased in CFS subjects. Discrepancies in neutrophil function have also been observed in some subjects with CFS with an overabundance of pre-apoptotic cells [<xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR48">48</xref>]. Significant alterations in NK cell signaling and function have also been observed in some populations with CFS such as in our previous work in older women, where the elimination of target erythroleukemic K562 cells by NK cells was significantly impaired in CFS [<xref ref-type="bibr" rid="CR27">27</xref>]. However Katz et al. [<xref ref-type="bibr" rid="CR34">34</xref>] studying a similar population to that reported here found normal NK cell number and function in adolescents with CFS following IM. In addition to differences in the ages of the subjects between the two previously cited studies, there were also differences in methodology; the latter assessed cytotoxic function of NK cell isolates while the former studied NK cell function in a mixed lymphocyte population.</p>
              <p>Involvement of sex-hormones in CFS is also consistent with our earlier work [<xref ref-type="bibr" rid="CR49">49</xref>] and that of others, in which women were significantly more affected by this illness than men [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. Our recent analysis using a theoretical model of regulatory physiology linking the hypothalamic-pituitary-adrenal (HPA) axis, the hypothalamic-pituitary-gonadal (HPG) and the peripheral immune system have shown that these interacting systems are especially prone in women to support chronically depressed cortisol levels and a persistent inflammatory signature consistent in some CFS populations [<xref ref-type="bibr" rid="CR50">50</xref>].</p>
              <p>Dysregulation of normal hypothalamic-pituitary-adrenal (HPA) axis function has been reported previously in patients with CFS [<xref ref-type="bibr" rid="CR51">51</xref>]. Again, in our previous study from this population, we found no evidence of consistently depressed salivary cortisol in adolescents with CFS compared with recovered controls when individual time points were compared, although 3 of 9 subjects with CFS did have depressed morning cortisol (versus 1 of 9 controls). We concluded that depressed salivary cortisol may be an uncommon factor in CFS as even in those cases where it might play a role it did not persist despite persistence of symptoms [<xref ref-type="bibr" rid="CR34">34</xref>]. In the current report, we found evidence of a group effect for depressed morning salivary cortisol as well as possibly other elements of hypothalamic-pituitary-thyroid (HPT) dysregulation with elevated free T4 at both 6 (<italic>p</italic> = 0.07) and 12 months (<italic>p</italic> = 0.08), which trended towards significance. These findings are also consistent with Fuite et al. [<xref ref-type="bibr" rid="CR52">52</xref>] who found evidence of re-modeling in neuro-endocrine and immune signaling in CFS. Specifically, results suggested a decreased cohesiveness in HPA axis response that coincided with a characteristic co-expression of immune markers with thyroid hormones in a larger group (<italic>n</italic> = 39) female CFS subjects. Changes in HPA axis feedback dynamics have also been reported recently by Aschbacher et al. [<xref ref-type="bibr" rid="CR51">51</xref>] who describe an abnormal increase in negative feedback along the HPA axis in CFS. If examined individually, the observed decreases in these markers, while statistically significant, may escape biological significance. For example, estradiol levels from 10 to 260 are all normal for either the luteal or follicular phases of the menstrual cycle. Our study is an ad hoc analysis of prospectively collected data. If confirmed prospectively, depressed ACTH and possibly glucose might offer an objective way to confirm the diagnosis of CFS at 6 months following IM, while persistence of increased T4 and decreased morning salivary cortisol coupled with decreased estradiol at 12 months and increased neutrophil counts at 24 months might provide objective evidence for the persistence of CFS. Whether any of these findings would be helpful earlier than 6 months following IM is not known.</p>
              <p>Limitations of this exploratory study include the small number of subjects (<italic>n</italic> = 13) and the relatively coarse sampling interval; nonetheless these were prospectively collected data from a study of PI-CFS with a well-defined trigger (IM). While these findings may not be applicable to the entire CFS population, a significant subset thereof reports onset coinciding with infectious illness. Though it is necessary validate these findings in a larger cohort, these initial results support the potential opportunity to identify individuals most at risk for developing CFS following IM and who might benefit from a more pro-active treatment. We purposely limited our assessment to common clinical markers in blood, saliva, and urine; while these readily available tests may not have the resolution to make a diagnosis, they may be sufficiently robust to support one. Indeed, additional means of confirmation using more focused laboratory assays as well as physiologic challenges to amplify these differences are being studied [<xref ref-type="bibr" rid="CR53">53</xref>]. For example, in applying a maximal exercise challenge to this cohort our group found significantly higher oxygen consumption, work slope, and peak oxygen pulse in recovered subjects versus patients diagnosed with PI-CFS at 6 months after IM [<xref ref-type="bibr" rid="CR54">54</xref>]. Other groups are reporting that such differences increase several fold in a follow-up challenge performed 24 h later [<xref ref-type="bibr" rid="CR55">55</xref>] suggesting that a stress test may be much more revealing than a standard assessment. These limitations not withstanding, we found evidence that the onset of PI-CFS may be associated with the expression of specific patterns of markers in standard blood work. Whether these markers are etiologically related to CFS also remains to be determined and further studies should include at least one comparator illness common to this age group.</p>
            </sec>
            <sec id="Sec9">
              <title>Conclusions</title>
              <p>In a first exploratory analysis of a clinical data set we found that assessment of stress and sex hormones as well as the relative proportion of innate immune cells using standard clinical laboratory tests may help support the diagnosis of PI-CFS in adolescents with IM. Specifically, early course deviations in ACTH and possibly glucose along with subsequent differences in the levels of morning salivary cortisol, T4 and estradiol might provide objective evidence for the onset and persistence of CFS. As the relative deviations in these markers evolve over time, their contribution to accuracy and robustness of classification is greatly improved if they are recorded longitudinally.</p>
            </sec>
          </body>
          <back>
            <app-group>
              <app id="App1">
                <sec id="Sec10">
                  <title>Additional files</title>
                  <p>
                    <media position="anchor" xlink:href="12887_2016_596_MOESM1_ESM.doc" id="MOESM1">
                      <label>Additional file 1: Table S1a.</label>
                      <caption>
                        <p>Summary descriptive statistics of clinical assays. Mean and standard deviation () of the conventional complete metabolic profiling in blood at 6, 12 and 24 months following diagnosis with IM. <bold>Table S1b</bold>. Summary descriptive statistics of clinical assays. Mean and standard deviation () of the conventional complete blood count (CBC) profiling in blood at 6, 12 and 24 months following diagnosis with IM. <bold>Table S1c</bold>. Summary descriptive statistics of clinical assays. Mean and standard deviation () of the conventional differential blood count profiling in blood at 6, 12 and 24 months following diagnosis with IM. Basophil count was not considered due to a large proportion of missing values. <bold>Table S1d</bold>. Summary descriptive statistics of clinical assays. Mean and standard deviation () of the conventional endocrine profiling in blood with urine specific gravity and pH at 6, 12 and 24 months following diagnosis with IM. (DOC 149 kb)</p>
                      </caption>
                    </media>
                    <media position="anchor" xlink:href="12887_2016_596_MOESM2_ESM.doc" id="MOESM2">
                      <label>Additional file 2: Table S2a.</label>
                      <caption>
                        <p>Summary of 2-way ANOVA. Significance of time, group and time x group effects of conventional metabolic profiling in blood across 6, 12 and 24 months following diagnosis with IM. False discovery rates (FDR) were based on Storey [<xref ref-type="bibr" rid="CR36">36</xref>] using the bootstrap (boot) and the polynomial (poly) fit methods to estimate lambda, as well as on by Benjamini and Hochberg [<xref ref-type="bibr" rid="CR37">37</xref>] (BH). <bold>Table S2b</bold>. Summary of 2-way ANOVA. Significance of time, group and time x group effects for complete blood count (CBC) profiling in blood across 6, 12 and 24 months following diagnosis with IM. False discovery rates (FDR) were based on Storey [<xref ref-type="bibr" rid="CR36">36</xref>] using the bootstrap (boot) and the polynomial (poly) fit methods to estimate lambda, as well as on by Benjamini and Hochberg [<xref ref-type="bibr" rid="CR37">37</xref>] (BH). <bold>Table S2c</bold>. Summary of 2-way ANOVA. Significance of time, group and time x group effects for conventional differential blood count profiling in blood across 6, 12 and 24 months following diagnosis with IM. False discovery rates (FDR) were based on Storey [<xref ref-type="bibr" rid="CR36">36</xref>] using the bootstrap (boot) and the polynomial (poly) fit methods to estimate lambda, as well as on by Benjamini and Hochberg [<xref ref-type="bibr" rid="CR37">37</xref>] (BH). Basophil count was not considered due to a large proportion of missing values. <bold>Table S2d</bold>. Summary of 2-way ANOVA. Significance of time, group and time x group effects for standard endocrine profiling in blood with urine specific gravity and pH across 6, 12 and 24 months following diagnosis with IM False discovery rates (FDR) were based on Storey [<xref ref-type="bibr" rid="CR36">36</xref>] using the bootstrap (boot) and the polynomial (poly) fit methods to estimate lambda, as well as on by Benjamini and Hochberg [<xref ref-type="bibr" rid="CR37">37</xref>] (BH). (DOC 150 kb)</p>
                      </caption>
                    </media>
                    <media position="anchor" xlink:href="12887_2016_596_MOESM3_ESM.xlsx" id="MOESM3">
                      <label>Additional file 3: Table S3a,b,c and d.</label>
                      <caption>
                        <p>Supplemental tables containing summary statistics describing the significance and probability of false discovery for the effects of time and the time x group interaction for each of the clinical markers using a regression-based repeated measures model. (XLSX 48 kb)</p>
                      </caption>
                    </media>
                  </p>
                </sec>
              </app>
            </app-group>
            <glossary>
              <title>Abbreviations</title>
              <def-list>
                <def-item>
                  <term>ACTH</term>
                  <def>
                    <p>adrenocorticotropic hormone</p>
                  </def>
                </def-item>
                <def-item>
                  <term>EBV</term>
                  <def>
                    <p>Epstein-Barr virus</p>
                  </def>
                </def-item>
                <def-item>
                  <term>IM</term>
                  <def>
                    <p>infectious mononucleosis</p>
                  </def>
                </def-item>
                <def-item>
                  <term>ME/CFS</term>
                  <def>
                    <p>myalgic encephalomyelitis/chronic fatigue syndrome</p>
                  </def>
                </def-item>
              </def-list>
            </glossary>
            <fn-group>
              <fn>
                <p>
                  <bold>Competing interests</bold>
                </p>
                <p>The authors declare that they have no competing interests.</p>
              </fn>
              <fn>
                <p>
                  <bold>Authors’ contributions</bold>
                </p>
                <p>JMH, AB, ZMB, and GB assembled the data and conducted all numerical analysis and drafted he initial manuscript. SDV, MO’G, MAF, BZK, RT, and NGK critically reviewed the manuscript. BZK and RT conceptualized, designed, and conducted the initial study. GB conceptualized, designed, and conducted this secondary analysis of the data. All authors read and approved the final manuscript.</p>
              </fn>
            </fn-group>
            <ack>
              <title>Acknowledgements</title>
              <p>This analysis was funded by the CFIDS Association of America grants to GB, BZK and NGK; all initial cohort recruitment and assessment were supported by US National Institutes of Health, R01 award HD043301-05 to PI RT, with secondary analysis also supported by R21AA016635 (PI MAF) and R01AI065723 (PI MAF); and R01AI065723 (PI MAF); the US Department of Veterans Affairs Merit Award to NGK.</p>
            </ack>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fukuda</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Straus</surname>
                      <given-names>SE</given-names>
                    </name>
                    <name>
                      <surname>Hickie</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Sharpe</surname>
                      <given-names>MC</given-names>
                    </name>
                    <name>
                      <surname>Dobbins</surname>
                      <given-names>JG</given-names>
                    </name>
                    <name>
                      <surname>Komaroff</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group</article-title>
                  <source>Ann Intern Med</source>
                  <year>1994</year>
                  <volume>121</volume>
                  <issue>12</issue>
                  <fpage>953</fpage>
                  <lpage>959</lpage>
                  <pub-id pub-id-type="doi">10.7326/0003-4819-121-12-199412150-00009</pub-id>
                  <?supplied-pmid 7978722?>
                  <pub-id pub-id-type="pmid">7978722</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chandler</surname>
                      <given-names>HK</given-names>
                    </name>
                    <name>
                      <surname>Ciccone</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>MacBride</surname>
                      <given-names>RJ</given-names>
                    </name>
                    <name>
                      <surname>Natelson</surname>
                      <given-names>B</given-names>
                    </name>
                  </person-group>
                  <article-title>Medically unexplained illness in short- and long-term disability applicants: prevalence and cost of salary reimbursement</article-title>
                  <source>Disabil Rehabil</source>
                  <year>2008</year>
                  <volume>30</volume>
                  <issue>16</issue>
                  <fpage>1185</fpage>
                  <lpage>1191</lpage>
                  <pub-id pub-id-type="doi">10.1080/09638280701500109</pub-id>
                  <?supplied-pmid 17852256?>
                  <pub-id pub-id-type="pmid">17852256</pub-id>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Reeves</surname>
                      <given-names>WC</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>JF</given-names>
                    </name>
                    <name>
                      <surname>Maloney</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Heim</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Hoaglin</surname>
                      <given-names>DC</given-names>
                    </name>
                    <name>
                      <surname>Boneva</surname>
                      <given-names>RS</given-names>
                    </name>
                    <name>
                      <surname>Morrissey</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Devlin</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Prevalence of chronic fatigue syndrome in metropolitan, urban, and rural Georgia</article-title>
                  <source>Popul Health Metr</source>
                  <year>2007</year>
                  <volume>5</volume>
                  <fpage>5</fpage>
                  <pub-id pub-id-type="doi">10.1186/1478-7954-5-5</pub-id>
                  <?supplied-pmid 17559660?>
                  <pub-id pub-id-type="pmid">17559660</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Reynolds</surname>
                      <given-names>KJ</given-names>
                    </name>
                    <name>
                      <surname>Vernon</surname>
                      <given-names>SD</given-names>
                    </name>
                    <name>
                      <surname>Bouchery</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Reeves</surname>
                      <given-names>WC</given-names>
                    </name>
                  </person-group>
                  <article-title>The economic impact of chronic fatigue syndrome</article-title>
                  <source>Cost Eff Resour Alloc</source>
                  <year>2004</year>
                  <volume>2</volume>
                  <issue>1</issue>
                  <fpage>4</fpage>
                  <pub-id pub-id-type="doi">10.1186/1478-7547-2-4</pub-id>
                  <?supplied-pmid 15210053?>
                  <pub-id pub-id-type="pmid">15210053</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jason</surname>
                      <given-names>LA</given-names>
                    </name>
                    <name>
                      <surname>Benton</surname>
                      <given-names>MC</given-names>
                    </name>
                    <name>
                      <surname>Valentine</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Johnson</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Torres-Harding</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>The economic impact of ME/CFS: individual and societal costs</article-title>
                  <source>Dyn Med</source>
                  <year>2008</year>
                  <volume>7</volume>
                  <fpage>6</fpage>
                  <pub-id pub-id-type="doi">10.1186/1476-5918-7-6</pub-id>
                  <?supplied-pmid 18397528?>
                  <pub-id pub-id-type="pmid">18397528</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jordan</surname>
                      <given-names>KM</given-names>
                    </name>
                    <name>
                      <surname>Jason</surname>
                      <given-names>LA</given-names>
                    </name>
                    <name>
                      <surname>Mears</surname>
                      <given-names>CJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Prevalence of pediatric chronic fatigue syndrome in a community-based sample</article-title>
                  <source>J of Chronic Fatigue Syndr</source>
                  <year>2006</year>
                  <volume>13</volume>
                  <fpage>75</fpage>
                  <lpage>78</lpage>
                  <pub-id pub-id-type="doi">10.1300/J092v13n02_04</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Marshall</surname>
                      <given-names>GS</given-names>
                    </name>
                    <name>
                      <surname>Gesser</surname>
                      <given-names>RM</given-names>
                    </name>
                    <name>
                      <surname>Yamanishi</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Starr</surname>
                      <given-names>SE</given-names>
                    </name>
                  </person-group>
                  <article-title>Chronic fatigue in children: clinical features, Epstein-Barr virus and human herpesvirus 6 serology and long term follow-up</article-title>
                  <source>Pediatr Infect Dis J</source>
                  <year>1991</year>
                  <volume>10</volume>
                  <issue>4</issue>
                  <fpage>287</fpage>
                  <lpage>290</lpage>
                  <pub-id pub-id-type="doi">10.1097/00006454-199104000-00004</pub-id>
                  <?supplied-pmid 1648198?>
                  <pub-id pub-id-type="pmid">1648198</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Richards</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Turk</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>White</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Children and adolescents with Chronic Fatigue Syndrome in non-specialist settings: beliefs, functional impairment and psychiatric disturbance</article-title>
                  <source>Eur Child Adolesc Psychiatry</source>
                  <year>2005</year>
                  <volume>14</volume>
                  <issue>6</issue>
                  <fpage>310</fpage>
                  <lpage>318</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00787-005-0477-4</pub-id>
                  <?supplied-pmid 16220215?>
                  <pub-id pub-id-type="pmid">16220215</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sankey</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Hill</surname>
                      <given-names>CM</given-names>
                    </name>
                    <name>
                      <surname>Brown</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Quinn</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Fletcher</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>A follow-up study of chronic fatigue syndrome in children and adolescents: symptom persistence and school absenteeism</article-title>
                  <source>Clin Child Psychol Psychiatry</source>
                  <year>2006</year>
                  <volume>11</volume>
                  <issue>1</issue>
                  <fpage>126</fpage>
                  <lpage>138</lpage>
                  <pub-id pub-id-type="doi">10.1177/1359104506059133</pub-id>
                  <?supplied-pmid 17087490?>
                  <pub-id pub-id-type="pmid">17087490</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>ter Wolbeek</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>van Doornen</surname>
                      <given-names>LJ</given-names>
                    </name>
                    <name>
                      <surname>Kavelaars</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Heijnen</surname>
                      <given-names>CJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Severe fatigue in adolescents: a common phenomenon?</article-title>
                  <source>Pediatrics</source>
                  <year>2006</year>
                  <volume>117</volume>
                  <issue>6</issue>
                  <fpage>e1078</fpage>
                  <lpage>e1086</lpage>
                  <pub-id pub-id-type="doi">10.1542/peds.2005-2575</pub-id>
                  <?supplied-pmid 16740810?>
                  <pub-id pub-id-type="pmid">16740810</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Reeves</surname>
                      <given-names>WC</given-names>
                    </name>
                    <name>
                      <surname>Lloyd</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Vernon</surname>
                      <given-names>SD</given-names>
                    </name>
                    <name>
                      <surname>Klimas</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Jason</surname>
                      <given-names>LA</given-names>
                    </name>
                    <name>
                      <surname>Bleijenberg</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Evengard</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>White</surname>
                      <given-names>PD</given-names>
                    </name>
                    <name>
                      <surname>Nisenbaum</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Unger</surname>
                      <given-names>ER</given-names>
                    </name>
                  </person-group>
                  <article-title>International Chronic Fatigue Syndrome Study Group. Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution</article-title>
                  <source>BMC Health Serv Res</source>
                  <year>2003</year>
                  <volume>3</volume>
                  <issue>1</issue>
                  <fpage>25</fpage>
                  <pub-id pub-id-type="doi">10.1186/1472-6963-3-25</pub-id>
                  <?supplied-pmid 14702202?>
                  <pub-id pub-id-type="pmid">14702202</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Salit</surname>
                      <given-names>IE</given-names>
                    </name>
                  </person-group>
                  <article-title>Precipitating factors for the chronic fatigue syndrome</article-title>
                  <source>J Psychiatr Res</source>
                  <year>1997</year>
                  <volume>31</volume>
                  <issue>1</issue>
                  <fpage>59</fpage>
                  <lpage>65</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0022-3956(96)00050-7</pub-id>
                  <?supplied-pmid 9201648?>
                  <pub-id pub-id-type="pmid">9201648</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Feder</surname>
                      <given-names>HM</given-names>
                      <suffix>Jr</suffix>
                    </name>
                    <name>
                      <surname>Dworkin</surname>
                      <given-names>PH</given-names>
                    </name>
                    <name>
                      <surname>Orkin</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Outcome of 48 pediatric patients with chronic fatigue. A clinical experience</article-title>
                  <source>Arch Fam Med</source>
                  <year>1994</year>
                  <volume>3</volume>
                  <issue>12</issue>
                  <fpage>1049</fpage>
                  <lpage>1055</lpage>
                  <pub-id pub-id-type="doi">10.1001/archfami.3.12.1049</pub-id>
                  <?supplied-pmid 7804489?>
                  <pub-id pub-id-type="pmid">7804489</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Krilov</surname>
                      <given-names>LR</given-names>
                    </name>
                    <name>
                      <surname>Fisher</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Friedman</surname>
                      <given-names>SB</given-names>
                    </name>
                    <name>
                      <surname>Reitman</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Mandel</surname>
                      <given-names>FS</given-names>
                    </name>
                  </person-group>
                  <article-title>Course and outcome of chronic fatigue in children and adolescents</article-title>
                  <source>Pediatrics</source>
                  <year>1998</year>
                  <volume>102</volume>
                  <issue>2 Pt 1</issue>
                  <fpage>360</fpage>
                  <lpage>366</lpage>
                  <pub-id pub-id-type="doi">10.1542/peds.102.2.360</pub-id>
                  <?supplied-pmid 9685439?>
                  <pub-id pub-id-type="pmid">9685439</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Smith</surname>
                      <given-names>MS</given-names>
                    </name>
                    <name>
                      <surname>Mitchell</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Corey</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Gold</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>McCauley</surname>
                      <given-names>EA</given-names>
                    </name>
                    <name>
                      <surname>Glover</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Tenover</surname>
                      <given-names>FC</given-names>
                    </name>
                  </person-group>
                  <article-title>Chronic fatigue in adolescents</article-title>
                  <source>Pediatrics</source>
                  <year>1991</year>
                  <volume>88</volume>
                  <issue>2</issue>
                  <fpage>195</fpage>
                  <lpage>202</lpage>
                  <?supplied-pmid 1861915?>
                  <pub-id pub-id-type="pmid">1861915</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Buchwald</surname>
                      <given-names>DS</given-names>
                    </name>
                    <name>
                      <surname>Rea</surname>
                      <given-names>TD</given-names>
                    </name>
                    <name>
                      <surname>Katon</surname>
                      <given-names>WJ</given-names>
                    </name>
                    <name>
                      <surname>Russo</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Ashley</surname>
                      <given-names>RL</given-names>
                    </name>
                  </person-group>
                  <article-title>Acute infectious mononucleosis: characteristics of patients who report failure to recover</article-title>
                  <source>Am J Med</source>
                  <year>2000</year>
                  <volume>109</volume>
                  <issue>7</issue>
                  <fpage>531</fpage>
                  <lpage>537</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0002-9343(00)00560-X</pub-id>
                  <?supplied-pmid 11063953?>
                  <pub-id pub-id-type="pmid">11063953</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hickie</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Davenport</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Wakefield</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Vollmer-Conna</surname>
                      <given-names>U</given-names>
                    </name>
                    <name>
                      <surname>Cameron</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Vernon</surname>
                      <given-names>SD</given-names>
                    </name>
                    <name>
                      <surname>Reeves</surname>
                      <given-names>WC</given-names>
                    </name>
                    <name>
                      <surname>Lloyd</surname>
                      <given-names>A</given-names>
                    </name>
                    <collab>Dubbo Infection Outcomes Study Group</collab>
                  </person-group>
                  <article-title>Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study</article-title>
                  <source>BMJ</source>
                  <year>2006</year>
                  <volume>333</volume>
                  <issue>7568</issue>
                  <fpage>575</fpage>
                  <pub-id pub-id-type="doi">10.1136/bmj.38933.585764.AE</pub-id>
                  <?supplied-pmid 16950834?>
                  <pub-id pub-id-type="pmid">16950834</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>White</surname>
                      <given-names>PD</given-names>
                    </name>
                    <name>
                      <surname>Thomas</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Kangro</surname>
                      <given-names>HO</given-names>
                    </name>
                    <name>
                      <surname>Bruce-Jones</surname>
                      <given-names>WD</given-names>
                    </name>
                    <name>
                      <surname>Amess</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Crawford</surname>
                      <given-names>DH</given-names>
                    </name>
                    <name>
                      <surname>Grover</surname>
                      <given-names>SA</given-names>
                    </name>
                    <name>
                      <surname>Clare</surname>
                      <given-names>AW</given-names>
                    </name>
                  </person-group>
                  <article-title>Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis</article-title>
                  <source>Lancet</source>
                  <year>2001</year>
                  <volume>358</volume>
                  <issue>9297</issue>
                  <fpage>1946</fpage>
                  <lpage>1954</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0140-6736(01)06961-6</pub-id>
                  <?supplied-pmid 11747919?>
                  <pub-id pub-id-type="pmid">11747919</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>White</surname>
                      <given-names>PD</given-names>
                    </name>
                    <name>
                      <surname>Thomas</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Amess</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Crawford</surname>
                      <given-names>DH</given-names>
                    </name>
                    <name>
                      <surname>Grover</surname>
                      <given-names>SA</given-names>
                    </name>
                    <name>
                      <surname>Kangro</surname>
                      <given-names>HO</given-names>
                    </name>
                    <name>
                      <surname>Clare</surname>
                      <given-names>AW</given-names>
                    </name>
                  </person-group>
                  <article-title>Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever</article-title>
                  <source>Br J Psychiatry</source>
                  <year>1998</year>
                  <volume>173</volume>
                  <fpage>475</fpage>
                  <lpage>481</lpage>
                  <pub-id pub-id-type="doi">10.1192/bjp.173.6.475</pub-id>
                  <?supplied-pmid 9926075?>
                  <pub-id pub-id-type="pmid">9926075</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rimes</surname>
                      <given-names>KA</given-names>
                    </name>
                    <name>
                      <surname>Goodman</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Hotopf</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Wessely</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Meltzer</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Chalder</surname>
                      <given-names>T</given-names>
                    </name>
                  </person-group>
                  <article-title>Incidence, prognosis, and risk factors for fatigue and chronic fatigue syndrome in adolescents: a prospective community study</article-title>
                  <source>Pediatrics</source>
                  <year>2007</year>
                  <volume>119</volume>
                  <issue>3</issue>
                  <fpage>e603</fpage>
                  <lpage>e609</lpage>
                  <pub-id pub-id-type="doi">10.1542/peds.2006-2231</pub-id>
                  <?supplied-pmid 17332180?>
                  <pub-id pub-id-type="pmid">17332180</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Candy</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Chalder</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Cleare</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <name>
                      <surname>Peakman</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Skowera</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Wessely</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Weinman</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Zuckerman</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Hotopf</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Predictors of fatigue following the onset of infectious mononucleosis</article-title>
                  <source>Psychol Med</source>
                  <year>2003</year>
                  <volume>33</volume>
                  <issue>5</issue>
                  <fpage>847</fpage>
                  <lpage>855</lpage>
                  <pub-id pub-id-type="doi">10.1017/S0033291703007554</pub-id>
                  <?supplied-pmid 12877399?>
                  <pub-id pub-id-type="pmid">12877399</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Katz</surname>
                      <given-names>BZ</given-names>
                    </name>
                    <name>
                      <surname>Shiraishi</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Mears</surname>
                      <given-names>CJ</given-names>
                    </name>
                    <name>
                      <surname>Binns</surname>
                      <given-names>HJ</given-names>
                    </name>
                    <name>
                      <surname>Taylor</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Chronic fatigue syndrome after infectious mononucleosis in adolescents</article-title>
                  <source>Pediatrics</source>
                  <year>2009</year>
                  <volume>124</volume>
                  <issue>1</issue>
                  <fpage>189</fpage>
                  <lpage>193</lpage>
                  <pub-id pub-id-type="doi">10.1542/peds.2008-1879</pub-id>
                  <?supplied-pmid 19564299?>
                  <pub-id pub-id-type="pmid">19564299</pub-id>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Carruthers</surname>
                      <given-names>BM</given-names>
                    </name>
                    <name>
                      <surname>Jain</surname>
                      <given-names>AK</given-names>
                    </name>
                    <name>
                      <surname>De Meirleir</surname>
                      <given-names>KL</given-names>
                    </name>
                    <name>
                      <surname>Peterson</surname>
                      <given-names>DL</given-names>
                    </name>
                    <name>
                      <surname>Klimas</surname>
                      <given-names>NG</given-names>
                    </name>
                    <name>
                      <surname>Lerner</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Bested</surname>
                      <given-names>AC</given-names>
                    </name>
                    <name>
                      <surname>Flor-Henry</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Joshi</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Powles</surname>
                      <given-names>ACP</given-names>
                    </name>
                    <name>
                      <surname>Sherkey</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>van de Sande</surname>
                      <given-names>MI</given-names>
                    </name>
                  </person-group>
                  <article-title>Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatments protocols</article-title>
                  <source>J Chron Fatigue Syndr</source>
                  <year>2003</year>
                  <volume>11</volume>
                  <fpage>7</fpage>
                  <lpage>115</lpage>
                  <pub-id pub-id-type="doi">10.1300/J092v11n01_02</pub-id>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jason</surname>
                      <given-names>LA</given-names>
                    </name>
                    <name>
                      <surname>Brown</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Evans</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Sunnquist</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Newton</surname>
                      <given-names>JL</given-names>
                    </name>
                  </person-group>
                  <article-title>Contrasting Chronic Fatigue Syndrome versus Myalgic Encephalomyelitis/Chronic Fatigue Syndrome</article-title>
                  <source>Fatigue</source>
                  <year>2013</year>
                  <volume>1</volume>
                  <issue>3</issue>
                  <fpage>168</fpage>
                  <lpage>183</lpage>
                  <?supplied-pmid 23914329?>
                  <pub-id pub-id-type="pmid">23914329</pub-id>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Klimas</surname>
                      <given-names>NG</given-names>
                    </name>
                    <name>
                      <surname>Broderick</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Fletcher</surname>
                      <given-names>MA</given-names>
                    </name>
                  </person-group>
                  <article-title>Biomarkers for chronic fatigue</article-title>
                  <source>Brain Behav Immun</source>
                  <year>2012</year>
                  <volume>26</volume>
                  <issue>8</issue>
                  <fpage>1202</fpage>
                  <lpage>1210</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bbi.2012.06.006</pub-id>
                  <?supplied-pmid 22732129?>
                  <pub-id pub-id-type="pmid">22732129</pub-id>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Brenu</surname>
                      <given-names>EW</given-names>
                    </name>
                    <name>
                      <surname>van Driel</surname>
                      <given-names>ML</given-names>
                    </name>
                    <name>
                      <surname>Staines</surname>
                      <given-names>DR</given-names>
                    </name>
                    <name>
                      <surname>Ashton</surname>
                      <given-names>KJ</given-names>
                    </name>
                    <name>
                      <surname>Ramos</surname>
                      <given-names>SB</given-names>
                    </name>
                    <name>
                      <surname>Keane</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Klimas</surname>
                      <given-names>NG</given-names>
                    </name>
                    <name>
                      <surname>Marshall-Gradisnik</surname>
                      <given-names>SM</given-names>
                    </name>
                  </person-group>
                  <article-title>Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis</article-title>
                  <source>J Transl Med</source>
                  <year>2011</year>
                  <volume>9</volume>
                  <fpage>81</fpage>
                  <pub-id pub-id-type="doi">10.1186/1479-5876-9-81</pub-id>
                  <?supplied-pmid 21619669?>
                  <pub-id pub-id-type="pmid">21619669</pub-id>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fletcher</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Zeng</surname>
                      <given-names>XR</given-names>
                    </name>
                    <name>
                      <surname>Maher</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Levis</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Hurwitz</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Antoni</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Broderick</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Klimas</surname>
                      <given-names>NG</given-names>
                    </name>
                  </person-group>
                  <article-title>Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26</article-title>
                  <source>PLoS One</source>
                  <year>2010</year>
                  <volume>5</volume>
                  <issue>5</issue>
                  <fpage>e10817</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0010817</pub-id>
                  <?supplied-pmid 20520837?>
                  <pub-id pub-id-type="pmid">20520837</pub-id>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fletcher</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Rosenthal</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Antoni</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Ironson</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Zeng</surname>
                      <given-names>XR</given-names>
                    </name>
                    <name>
                      <surname>Barnes</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Harvey</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Hurwitz</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Levis</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Broderick</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Klimas</surname>
                      <given-names>NG</given-names>
                    </name>
                  </person-group>
                  <article-title>Plasma neuropeptide Y: a biomarker for symptom severity in chronic fatigue syndrome</article-title>
                  <source>Behav Brain Funct</source>
                  <year>2010</year>
                  <volume>6</volume>
                  <fpage>76</fpage>
                  <pub-id pub-id-type="doi">10.1186/1744-9081-6-76</pub-id>
                  <?supplied-pmid 21190576?>
                  <pub-id pub-id-type="pmid">21190576</pub-id>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Papadopoulos</surname>
                      <given-names>AS</given-names>
                    </name>
                    <name>
                      <surname>Cleare</surname>
                      <given-names>AJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome</article-title>
                  <source>Nat Rev Endocrinol</source>
                  <year>2011</year>
                  <volume>8</volume>
                  <issue>1</issue>
                  <fpage>22</fpage>
                  <lpage>32</lpage>
                  <pub-id pub-id-type="doi">10.1038/nrendo.2011.153</pub-id>
                  <?supplied-pmid 21946893?>
                  <pub-id pub-id-type="pmid">21946893</pub-id>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Curriu</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Carrillo</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Massanella</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Rigau</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Alegre</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Puig</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Garcia-Quintana</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Castro-Marrero</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Negredo</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Clotet</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Cabrera</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Blanco</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Screening NK-B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome</article-title>
                  <source>J Transl Med</source>
                  <year>2013</year>
                  <volume>11</volume>
                  <fpage>68</fpage>
                  <pub-id pub-id-type="doi">10.1186/1479-5876-11-68</pub-id>
                  <?supplied-pmid 23514202?>
                  <pub-id pub-id-type="pmid">23514202</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Broderick</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Katz</surname>
                      <given-names>BZ</given-names>
                    </name>
                    <name>
                      <surname>Fernandes</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Fletcher</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Klimas</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>FA</given-names>
                    </name>
                    <name>
                      <surname>O’Gorman</surname>
                      <given-names>MR</given-names>
                    </name>
                    <name>
                      <surname>Vernon</surname>
                      <given-names>SD</given-names>
                    </name>
                    <name>
                      <surname>Taylor</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue</article-title>
                  <source>J Transl Med</source>
                  <year>2012</year>
                  <volume>10</volume>
                  <fpage>191</fpage>
                  <pub-id pub-id-type="doi">10.1186/1479-5876-10-191</pub-id>
                  <?supplied-pmid 22973830?>
                  <pub-id pub-id-type="pmid">22973830</pub-id>
                </element-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jason</surname>
                      <given-names>LA</given-names>
                    </name>
                    <name>
                      <surname>Jordan</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Miike</surname>
                      <given-names>T</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A pediatric case definition for myalgic encephalomyelitis and chronic fatigue syndrome</article-title>
                  <source>J Chronic Fatigue Syndr</source>
                  <year>2006</year>
                  <volume>13</volume>
                  <fpage>1</fpage>
                  <lpage>44</lpage>
                  <pub-id pub-id-type="doi">10.1300/J092v13n02_01</pub-id>
                </element-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jason</surname>
                      <given-names>LA</given-names>
                    </name>
                    <name>
                      <surname>Richman</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Rademaker</surname>
                      <given-names>AW</given-names>
                    </name>
                    <name>
                      <surname>Jordan</surname>
                      <given-names>KM</given-names>
                    </name>
                    <name>
                      <surname>Plioplys</surname>
                      <given-names>AV</given-names>
                    </name>
                    <name>
                      <surname>Taylor</surname>
                      <given-names>RR</given-names>
                    </name>
                    <name>
                      <surname>McCready</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>CF</given-names>
                    </name>
                    <name>
                      <surname>Plioplys</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>A community-based study of chronic fatigue syndrome</article-title>
                  <source>Arch Intern Med</source>
                  <year>1999</year>
                  <volume>159</volume>
                  <issue>18</issue>
                  <fpage>2129</fpage>
                  <lpage>2137</lpage>
                  <pub-id pub-id-type="doi">10.1001/archinte.159.18.2129</pub-id>
                  <?supplied-pmid 10527290?>
                  <pub-id pub-id-type="pmid">10527290</pub-id>
                </element-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Katz</surname>
                      <given-names>BZ</given-names>
                    </name>
                    <name>
                      <surname>Zimmerman</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>O’Gorman</surname>
                      <given-names>MRG</given-names>
                    </name>
                    <name>
                      <surname>Mears</surname>
                      <given-names>CJ</given-names>
                    </name>
                    <name>
                      <surname>Shiraishi</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Taylor</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Normal Salivary Cortisol and NK Cell Function in Adolescents With Chronic Fatigue Syndrome Following Infectious Mononucleosis</article-title>
                  <source>Arch Pediatr Infect Dis</source>
                  <year>2013</year>
                  <volume>1</volume>
                  <issue>5</issue>
                  <fpage>211</fpage>
                  <lpage>216</lpage>
                  <pub-id pub-id-type="doi">10.5812/pedinfect.13107</pub-id>
                </element-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sun</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>McLain</surname>
                      <given-names>AC</given-names>
                    </name>
                  </person-group>
                  <article-title>Multiple Testing of Composite Null Hypotheses in Heteroscedastic Models</article-title>
                  <source>J Am Stat Assoc</source>
                  <year>2012</year>
                  <volume>107</volume>
                  <issue>498</issue>
                  <fpage>673</fpage>
                  <lpage>687</lpage>
                  <pub-id pub-id-type="doi">10.1080/01621459.2012.664505</pub-id>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Storey</surname>
                      <given-names>JD</given-names>
                    </name>
                  </person-group>
                  <article-title>A direct approach to false discovery rates</article-title>
                  <source>J R Stat Soc</source>
                  <year>2002</year>
                  <volume>64</volume>
                  <issue>3</issue>
                  <fpage>479</fpage>
                  <lpage>498</lpage>
                  <pub-id pub-id-type="doi">10.1111/1467-9868.00346</pub-id>
                </element-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Benjamini</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Hochberg</surname>
                      <given-names>Y</given-names>
                    </name>
                  </person-group>
                  <article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title>
                  <source>J R Statist Soc B</source>
                  <year>1995</year>
                  <volume>57</volume>
                  <issue>1</issue>
                  <fpage>289</fpage>
                  <lpage>300</lpage>
                </element-citation>
              </ref>
              <ref id="CR38">
                <label>38.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rawlings</surname>
                      <given-names>JO</given-names>
                    </name>
                  </person-group>
                  <person-group person-group-type="editor">
                    <name>
                      <surname>Barndorff-Nielsen</surname>
                      <given-names>OE</given-names>
                    </name>
                    <name>
                      <surname>Bickel</surname>
                      <given-names>PJ</given-names>
                    </name>
                    <name>
                      <surname>Cleveland</surname>
                      <given-names>WS</given-names>
                    </name>
                    <name>
                      <surname>Dudley</surname>
                      <given-names>RM</given-names>
                    </name>
                  </person-group>
                  <article-title>Collinearity Diagnostics</article-title>
                  <source>Applied Regression Analysis</source>
                  <year>1988</year>
                  <publisher-loc>Pacific Grove</publisher-loc>
                  <publisher-name>Wadsworth and Brooks</publisher-name>
                  <fpage>273</fpage>
                  <lpage>281</lpage>
                </element-citation>
              </ref>
              <ref id="CR39">
                <label>39.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Draper</surname>
                      <given-names>NR</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <article-title>Stepwise Regression</article-title>
                  <source>Applied Regression Analysis</source>
                  <year>1998</year>
                  <publisher-loc>Hoboken, NJ</publisher-loc>
                  <publisher-name>Wiley-Interscience</publisher-name>
                  <fpage>307</fpage>
                  <lpage>312</lpage>
                </element-citation>
              </ref>
              <ref id="CR40">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Greiner</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Pfeiffer</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>RD</given-names>
                    </name>
                  </person-group>
                  <article-title>Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests</article-title>
                  <source>Prev Vet Med</source>
                  <year>2000</year>
                  <volume>45</volume>
                  <issue>1–2</issue>
                  <fpage>23</fpage>
                  <lpage>41</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0167-5877(00)00115-X</pub-id>
                  <?supplied-pmid 10802332?>
                  <pub-id pub-id-type="pmid">10802332</pub-id>
                </element-citation>
              </ref>
              <ref id="CR41">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zurakowski</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Johnson</surname>
                      <given-names>VM</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>EY</given-names>
                    </name>
                  </person-group>
                  <article-title>Biostatistics in clinical decision making for cardiothoracic radiologists</article-title>
                  <source>J Thorac Imaging</source>
                  <year>2013</year>
                  <volume>28</volume>
                  <issue>6</issue>
                  <fpage>368</fpage>
                  <lpage>375</lpage>
                  <pub-id pub-id-type="doi">10.1097/RTI.0b013e318281db88</pub-id>
                  <?supplied-pmid 23358369?>
                  <pub-id pub-id-type="pmid">23358369</pub-id>
                </element-citation>
              </ref>
              <ref id="CR42">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Langlotz</surname>
                      <given-names>CP</given-names>
                    </name>
                  </person-group>
                  <article-title>Fundamental measures of diagnostic examination performance: usefulness for clinical decision making and research</article-title>
                  <source>Radiology</source>
                  <year>2003</year>
                  <volume>228</volume>
                  <issue>1</issue>
                  <fpage>3</fpage>
                  <lpage>9</lpage>
                  <pub-id pub-id-type="doi">10.1148/radiol.2281011106</pub-id>
                  <?supplied-pmid 12832567?>
                  <pub-id pub-id-type="pmid">12832567</pub-id>
                </element-citation>
              </ref>
              <ref id="CR43">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nguyen</surname>
                      <given-names>AT</given-names>
                    </name>
                    <name>
                      <surname>Mandard</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Dray</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Deckert</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Valet</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Besnard</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Drucker</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <name>
                      <surname>Lagrost</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Grober</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Lipopolysaccharides-mediated increase in glucose-stimulated insulin secretion: involvement of the GLP-1 pathway</article-title>
                  <source>Diabetes</source>
                  <year>2014</year>
                  <volume>63</volume>
                  <issue>2</issue>
                  <fpage>471</fpage>
                  <lpage>482</lpage>
                  <pub-id pub-id-type="doi">10.2337/db13-0903</pub-id>
                  <?supplied-pmid 24186868?>
                  <pub-id pub-id-type="pmid">24186868</pub-id>
                </element-citation>
              </ref>
              <ref id="CR44">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tweedell</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Mulligan</surname>
                      <given-names>KX</given-names>
                    </name>
                    <name>
                      <surname>Martel</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Chueh</surname>
                      <given-names>FY</given-names>
                    </name>
                    <name>
                      <surname>Santomango</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>McGuinness</surname>
                      <given-names>OP</given-names>
                    </name>
                  </person-group>
                  <article-title>Metabolic response to endotoxin in vivo in the conscious mouse: role of interleukin-6</article-title>
                  <source>Metabolism</source>
                  <year>2011</year>
                  <volume>60</volume>
                  <fpage>92</fpage>
                  <lpage>98</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.metabol.2009.12.022</pub-id>
                  <?supplied-pmid 20102773?>
                  <pub-id pub-id-type="pmid">20102773</pub-id>
                </element-citation>
              </ref>
              <ref id="CR45">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cannon</surname>
                      <given-names>JG</given-names>
                    </name>
                    <name>
                      <surname>Angel</surname>
                      <given-names>JB</given-names>
                    </name>
                    <name>
                      <surname>Abad</surname>
                      <given-names>LW</given-names>
                    </name>
                    <name>
                      <surname>O’Grady</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Lundgren</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Fagioli</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Komaroff</surname>
                      <given-names>AL</given-names>
                    </name>
                  </person-group>
                  <article-title>Hormonal influences on stress-induced neutrophil mobilization in health and chronic fatigue syndrome</article-title>
                  <source>J Clin Immunol</source>
                  <year>1998</year>
                  <volume>18</volume>
                  <issue>4</issue>
                  <fpage>291</fpage>
                  <lpage>298</lpage>
                  <pub-id pub-id-type="doi">10.1023/A:1027389907780</pub-id>
                  <?supplied-pmid 9710746?>
                  <pub-id pub-id-type="pmid">9710746</pub-id>
                </element-citation>
              </ref>
              <ref id="CR46">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Niblett</surname>
                      <given-names>SH</given-names>
                    </name>
                    <name>
                      <surname>King</surname>
                      <given-names>KE</given-names>
                    </name>
                    <name>
                      <surname>Dunstan</surname>
                      <given-names>RH</given-names>
                    </name>
                    <name>
                      <surname>Clifton-Bligh</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Hoskin</surname>
                      <given-names>LA</given-names>
                    </name>
                    <name>
                      <surname>Roberts</surname>
                      <given-names>TK</given-names>
                    </name>
                    <name>
                      <surname>Fulcher</surname>
                      <given-names>GR</given-names>
                    </name>
                    <name>
                      <surname>McGregor</surname>
                      <given-names>NR</given-names>
                    </name>
                    <name>
                      <surname>Dunsmore</surname>
                      <given-names>JC</given-names>
                    </name>
                    <name>
                      <surname>Butt</surname>
                      <given-names>HL</given-names>
                    </name>
                    <name>
                      <surname>Klineberg</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Rothkirch</surname>
                      <given-names>TB</given-names>
                    </name>
                  </person-group>
                  <article-title>Hematologic and urinary excretion anomalies in patients with chronic fatigue syndrome</article-title>
                  <source>Exp Biol Med (Maywood)</source>
                  <year>2007</year>
                  <volume>232</volume>
                  <issue>8</issue>
                  <fpage>1041</fpage>
                  <lpage>1049</lpage>
                  <pub-id pub-id-type="doi">10.3181/0702-RM-44</pub-id>
                  <pub-id pub-id-type="pmid">17720950</pub-id>
                </element-citation>
              </ref>
              <ref id="CR47">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kennedy</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Spence</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Underwood</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Belch</surname>
                      <given-names>JJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Increased neutrophil apoptosis in chronic fatigue syndrome</article-title>
                  <source>J Clin Pathol</source>
                  <year>2004</year>
                  <volume>57</volume>
                  <issue>8</issue>
                  <fpage>891</fpage>
                  <lpage>893</lpage>
                  <pub-id pub-id-type="doi">10.1136/jcp.2003.015511</pub-id>
                  <?supplied-pmid 15280416?>
                  <pub-id pub-id-type="pmid">15280416</pub-id>
                </element-citation>
              </ref>
              <ref id="CR48">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Brenu</surname>
                      <given-names>EW</given-names>
                    </name>
                    <name>
                      <surname>Staines</surname>
                      <given-names>DR</given-names>
                    </name>
                    <name>
                      <surname>Baskurt</surname>
                      <given-names>OK</given-names>
                    </name>
                    <name>
                      <surname>Ashton</surname>
                      <given-names>KJ</given-names>
                    </name>
                    <name>
                      <surname>Ramos</surname>
                      <given-names>SB</given-names>
                    </name>
                    <name>
                      <surname>Christy</surname>
                      <given-names>RM</given-names>
                    </name>
                    <name>
                      <surname>Marshall-Gradisnik</surname>
                      <given-names>SM</given-names>
                    </name>
                  </person-group>
                  <article-title>Immune and hemorheological changes in chronic fatigue syndrome</article-title>
                  <source>J Transl Med</source>
                  <year>2010</year>
                  <volume>8</volume>
                  <fpage>1</fpage>
                  <pub-id pub-id-type="doi">10.1186/1479-5876-8-1</pub-id>
                  <?supplied-pmid 20064266?>
                  <pub-id pub-id-type="pmid">20064266</pub-id>
                </element-citation>
              </ref>
              <ref id="CR49">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Smylie</surname>
                      <given-names>AL</given-names>
                    </name>
                    <name>
                      <surname>Broderick</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Fernandes</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Razdan</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Barnes</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Collado</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Sol</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Fletcher</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Klimas</surname>
                      <given-names>N</given-names>
                    </name>
                  </person-group>
                  <article-title>A comparison of sex-specific immune signatures in Gulf War illness and chronic fatigue syndrome</article-title>
                  <source>BMC Immunol</source>
                  <year>2013</year>
                  <volume>14</volume>
                  <fpage>29</fpage>
                  <pub-id pub-id-type="doi">10.1186/1471-2172-14-29</pub-id>
                  <?supplied-pmid 23800166?>
                  <pub-id pub-id-type="pmid">23800166</pub-id>
                </element-citation>
              </ref>
              <ref id="CR50">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Craddock</surname>
                      <given-names>TJ</given-names>
                    </name>
                    <name>
                      <surname>Fritsch</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Rice</surname>
                      <given-names>MA</given-names>
                      <suffix>Jr</suffix>
                    </name>
                    <name>
                      <surname>del Rosario</surname>
                      <given-names>RM</given-names>
                    </name>
                    <name>
                      <surname>Miller</surname>
                      <given-names>DB</given-names>
                    </name>
                    <name>
                      <surname>Fletcher</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Klimas</surname>
                      <given-names>NG</given-names>
                    </name>
                    <name>
                      <surname>Broderick</surname>
                      <given-names>G</given-names>
                    </name>
                  </person-group>
                  <article-title>A role for homeostatic drive in the perpetuation of complex chronic illness: Gulf War Illness and chronic fatigue syndrome</article-title>
                  <source>PLoS One</source>
                  <year>2014</year>
                  <volume>9</volume>
                  <issue>1</issue>
                  <fpage>e84839</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0084839</pub-id>
                  <?supplied-pmid 24416298?>
                  <pub-id pub-id-type="pmid">24416298</pub-id>
                </element-citation>
              </ref>
              <ref id="CR51">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Aschbacher</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Adam</surname>
                      <given-names>EK</given-names>
                    </name>
                    <name>
                      <surname>Crofford</surname>
                      <given-names>LJ</given-names>
                    </name>
                    <name>
                      <surname>Kemeny</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Demitrack</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Ben-Zvi</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Linking disease symptoms and subtypes with personalized systems based phenotypes: A proof of concept study</article-title>
                  <source>Brain Behav Immun</source>
                  <year>2012</year>
                  <volume>26</volume>
                  <issue>7</issue>
                  <fpage>1047</fpage>
                  <lpage>1056</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bbi.2012.06.002</pub-id>
                  <?supplied-pmid 22687333?>
                  <pub-id pub-id-type="pmid">22687333</pub-id>
                </element-citation>
              </ref>
              <ref id="CR52">
                <label>52.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fuite</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Vernon</surname>
                      <given-names>SD</given-names>
                    </name>
                    <name>
                      <surname>Broderick</surname>
                      <given-names>G</given-names>
                    </name>
                  </person-group>
                  <article-title>Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis</article-title>
                  <source>Genomics</source>
                  <year>2008</year>
                  <volume>92</volume>
                  <issue>6</issue>
                  <fpage>393</fpage>
                  <lpage>399</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ygeno.2008.08.008</pub-id>
                  <?supplied-pmid 18775774?>
                  <pub-id pub-id-type="pmid">18775774</pub-id>
                </element-citation>
              </ref>
              <ref id="CR53">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Maes</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Twisk</surname>
                      <given-names>FN</given-names>
                    </name>
                    <name>
                      <surname>Johnson</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Myalgic Encephalomyelitis (ME), Chronic Fatigue Syndrome (CFS), and Chronic Fatigue (CF) are distinguished accurately: results of supervised learning techniques applied on clinical and inflammatory data</article-title>
                  <source>Psychiatry Res</source>
                  <year>2012</year>
                  <volume>200</volume>
                  <issue>2–3</issue>
                  <fpage>754</fpage>
                  <lpage>760</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.psychres.2012.03.031</pub-id>
                  <?supplied-pmid 22521895?>
                  <pub-id pub-id-type="pmid">22521895</pub-id>
                </element-citation>
              </ref>
              <ref id="CR54">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Katz</surname>
                      <given-names>BZ</given-names>
                    </name>
                    <name>
                      <surname>Boas</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Shiraishi</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Mears</surname>
                      <given-names>CJ</given-names>
                    </name>
                    <name>
                      <surname>Taylor</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Exercise tolerance testing in a prospective cohort of adolescents with chronic fatigue syndrome and recovered controls following infectious mononucleosis</article-title>
                  <source>J Pediatr</source>
                  <year>2010</year>
                  <volume>157</volume>
                  <issue>3</issue>
                  <fpage>468</fpage>
                  <lpage>472</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jpeds.2010.03.025</pub-id>
                  <?supplied-pmid 20447647?>
                  <pub-id pub-id-type="pmid">20447647</pub-id>
                </element-citation>
              </ref>
              <ref id="CR55">
                <label>55.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Snell</surname>
                      <given-names>CR</given-names>
                    </name>
                    <name>
                      <surname>Stevens</surname>
                      <given-names>SR</given-names>
                    </name>
                    <name>
                      <surname>Davenport</surname>
                      <given-names>TE</given-names>
                    </name>
                    <name>
                      <surname>Van Ness</surname>
                      <given-names>JM</given-names>
                    </name>
                  </person-group>
                  <article-title>Discriminative validity of metabolic and workload measurements for identifying people with chronic fatigue syndrome</article-title>
                  <source>Phys Ther</source>
                  <year>2013</year>
                  <volume>93</volume>
                  <issue>11</issue>
                  <fpage>1484</fpage>
                  <lpage>1492</lpage>
                  <pub-id pub-id-type="doi">10.2522/ptj.20110368</pub-id>
                  <?supplied-pmid 23813081?>
                  <pub-id pub-id-type="pmid">23813081</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
